Simplex Trading, LLC Biovie Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$0.4 - $0.56 $582 - $814	-1,455 Reduced 52.09%	1,338 $0
Q1 2024 Apr 25, 2024	SELL	$0.53 - $1.89 $6,884 - $24,551	-12,990 Reduced 82.3%	2,793 $1,000
Q4 2023 Feb 02, 2024	SELL	$1.22 - $5.24 $5,685 - $24,418	-4,660 Reduced 22.8%	15,783 $19,000
Q3 2023 Nov 01, 2023	BUY	$2.75 - $5.17 $28,902 - $54,336	10,510 Added 105.81%	20,443 $69,000
Q2 2023 Aug 04, 2023	BUY	$4.09 - $8.29 $40,625 - $82,344	9,933 New	9,933 $42,000

340K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $92M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.